Sub-Community 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Siblings 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] Community Statistics 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1611277(30.06%) 最後更新時間: 2024-11-28 18:37 Top Upload Loading... Top Download Loading... Recent Submissions Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 751-775 of 2409. (97 Page(s) Totally) << < 26 27 28 29 30 31 32 33 34 35 > >> View [10|25|50] records per page

Date	Title	Relation
2018-10-01	Protein phosphatase 2A as therapeutic targets in various disease models	Life Sciences. 2018 Oct 1;210:40-46.
2018-10	Inflammatory response and PM2.5 exposure of urban traffic conductors	Aerosol and Air Quality Research. 2018 Oct;18(10):2633-2642.
2018-10	Identification of novel Cdc7 kinase inhibitors as anti-cancer agents that target the interaction with Dbf4 by the fragment complementation and drug repositioning approach	EBioMedicine. 2018 Oct;36:241-251.
2018-10	Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P.
2018-10	NAPOLI-1 phase III trial outcomes by prior surgery, and disease stage, in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 733P.
2018-10	The prognostic value of the modified glasgow prognostic score (mGPS) in predicting overall survival (OS) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV)	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 749P.
2018-10	Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV): Survival analysis from NAPOLI-1	Annals of Oncology. 2018 Oct;29(Suppl. 8):250-251.
2018-10	M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-beta, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 757P.
2018-10	Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 626PD.
2018-09-26	Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma	Experimental and Therapeutic Medicine. 2018 Sep 26;16(6):4810-4816.
2018-09-15	Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer	American Journal of Cancer Research. 2018 Sep 15;8(9):1812-1822.
2018-09-06	Cell motility facilitated by mono(2-ethylhexyl) phthalate via activation of the AKT-beta-catenin-IL-8 axis in colorectal cancer	Journal of Agricultural and Food Chemistry. 2018 Sep 6;66(37):9635-9644.
2018-09	Evaluation of total and IgA-specific antibody targeting Epstein-Barr virus glycoprotein 350 and nasopharyngeal carcinoma risk	Journal of Infectious Disease. 2018 Sep;218(6):886-891.
2018-09	Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study	Annals of Oncology. 2018 Sep;29(9):1972-1979.
2018-09	Outcomes for cervical cancer patients treated with radiation in high-volume and low-volume hospitals	International Journal of Radiation Oncology Biology Physics. 2018 Sep;102(1):184-193.
2018-09	Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study	Medicine. 2018 Sep;97(36):Article number e12268.
2018-09	Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials	Oncology Research and Treatment. 2018 Sep;41(Suppl. 4):285-286.
2018-08-24	BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor	Cancer Science. 2018 Nov;109(11):3591-3601.
2018-08-13	Molecular targets in hepatocarcinogenesis and implications for therapy	Journal of Clinical Medicine. 2018 Aug 13;7(8):Article number 213.
2018-08	Stem cell transplantation for T-cell lymphomas in Taiwan	Bone Marrow Transplantation. 2018 Aug;53(8):993-1000.
2018-08	Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection	Journal of Hepatology. 2018 Aug;69(2):286-292.
2018-07-30	High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy	International Journal of Medical Sciences. 2018 Jul 30;15(11):1171-1178.
2018-07-27	免疫調節細胞の作出方法、それから作出された細胞、およびその使用	JP6374924/2018-07-27
2018-07	Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis	Journal of Cellular Physiology. 2018 Jul;233(7):5458-5467.
2018-07	The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients	Journal of the Chinese Medical Association. 2018 Jul;81(7):593-598.

Showing items 751-775 of 2409. (97 Page(s) Totally) << < 26 27 28 29 30 31 32 33 34 35 > >> View [10|25|50] records per page